Morgan Stanley lowered the firm’s price target on Goldman Sachs (GS) to $659 from $782 and keeps an Overweight rating on the shares. The robust ...

US equities are pricing in a recession risk much bigger than credit markets, leaving room for a positive surprise, according ...

U.S. stocks have suffered their sharpest selloff in months over recent days as investors have grown nervous that President ...

Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price target hoisted by equities researchers at Morgan Stanley from $123.00 to $130.00 in a research note issued to investors on ...

Afya (NASDAQ:AFYA – Get Free Report) was downgraded by investment analysts at Morgan Stanley from an “equal weight” rating to ...

The current Wall Street sell-off has wiped out billions in market value, hammering tech giants, banks, and airlines while ...

Australian shares are set to open lower. Broad selling hit New York. Meta and Tesla dragged the megacap techs down. Follow ...

Intel stock jumped more than 16% after announcing that tech executive and former board member Lip-Bu Tan will be the ...

"WFC is also well capitalized and is likely to see regulatory relief under the expectation of a less onerous regulatory environment," the RBC analyst wrote. "Lastly, the optimization of expense levels ...

Nvidia-backed artificial intelligence startup CoreWeave has inked a five-year, $11.9 billion deal with OpenAI ahead of its ...

Shares of KKR & Co. Inc. slid 4.97% to $108.69 Thursday, on what proved to be an all-around dismal trading session for the ...